Your browser doesn't support javascript.
loading
Enduring epigenetic landmarks define the cancer microenvironment.
Pidsley, Ruth; Lawrence, Mitchell G; Zotenko, Elena; Niranjan, Birunthi; Statham, Aaron; Song, Jenny; Chabanon, Roman M; Qu, Wenjia; Wang, Hong; Richards, Michelle; Nair, Shalima S; Armstrong, Nicola J; Nim, Hieu T; Papargiris, Melissa; Balanathan, Preetika; French, Hugh; Peters, Timothy; Norden, Sam; Ryan, Andrew; Pedersen, John; Kench, James; Daly, Roger J; Horvath, Lisa G; Stricker, Phillip; Frydenberg, Mark; Taylor, Renea A; Stirzaker, Clare; Risbridger, Gail P; Clark, Susan J.
Afiliação
  • Pidsley R; Epigenetics Research Laboratory, Genomics and Epigenetics Division, Garvan Institute of Medical Research, Darlinghurst, Sydney, New South Wales 2010, Australia.
  • Lawrence MG; St. Vincent's Clinical School, UNSW Sydney, New South Wales 2052, Australia.
  • Zotenko E; Prostate Research Group, Cancer Program-Biomedicine Discovery Institute, Department of Anatomy and Developmental Biology, Monash Partners Comprehensive Cancer Consortium, Monash University, Clayton, Victoria 3800, Australia.
  • Niranjan B; Prostate Cancer Translational Research Program, Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia.
  • Statham A; Epigenetics Research Laboratory, Genomics and Epigenetics Division, Garvan Institute of Medical Research, Darlinghurst, Sydney, New South Wales 2010, Australia.
  • Song J; St. Vincent's Clinical School, UNSW Sydney, New South Wales 2052, Australia.
  • Chabanon RM; Prostate Research Group, Cancer Program-Biomedicine Discovery Institute, Department of Anatomy and Developmental Biology, Monash Partners Comprehensive Cancer Consortium, Monash University, Clayton, Victoria 3800, Australia.
  • Qu W; Epigenetics Research Laboratory, Genomics and Epigenetics Division, Garvan Institute of Medical Research, Darlinghurst, Sydney, New South Wales 2010, Australia.
  • Wang H; Epigenetics Research Laboratory, Genomics and Epigenetics Division, Garvan Institute of Medical Research, Darlinghurst, Sydney, New South Wales 2010, Australia.
  • Richards M; Epigenetics Research Laboratory, Genomics and Epigenetics Division, Garvan Institute of Medical Research, Darlinghurst, Sydney, New South Wales 2010, Australia.
  • Nair SS; Epigenetics Research Laboratory, Genomics and Epigenetics Division, Garvan Institute of Medical Research, Darlinghurst, Sydney, New South Wales 2010, Australia.
  • Armstrong NJ; Prostate Research Group, Cancer Program-Biomedicine Discovery Institute, Department of Anatomy and Developmental Biology, Monash Partners Comprehensive Cancer Consortium, Monash University, Clayton, Victoria 3800, Australia.
  • Nim HT; Prostate Research Group, Cancer Program-Biomedicine Discovery Institute, Department of Anatomy and Developmental Biology, Monash Partners Comprehensive Cancer Consortium, Monash University, Clayton, Victoria 3800, Australia.
  • Papargiris M; Epigenetics Research Laboratory, Genomics and Epigenetics Division, Garvan Institute of Medical Research, Darlinghurst, Sydney, New South Wales 2010, Australia.
  • Balanathan P; St. Vincent's Clinical School, UNSW Sydney, New South Wales 2052, Australia.
  • French H; Epigenetics Research Laboratory, Genomics and Epigenetics Division, Garvan Institute of Medical Research, Darlinghurst, Sydney, New South Wales 2010, Australia.
  • Peters T; Mathematics and Statistics, Murdoch University, Perth, Western Australia 6150, Australia.
  • Norden S; Prostate Research Group, Cancer Program-Biomedicine Discovery Institute, Department of Anatomy and Developmental Biology, Monash Partners Comprehensive Cancer Consortium, Monash University, Clayton, Victoria 3800, Australia.
  • Ryan A; Faculty of Information Technology, Monash University, Clayton, Victoria 3800, Australia.
  • Pedersen J; Australian Regenerative Medicine Institute, Monash University, Clayton, Victoria 3800, Australia.
  • Kench J; Prostate Research Group, Cancer Program-Biomedicine Discovery Institute, Department of Anatomy and Developmental Biology, Monash Partners Comprehensive Cancer Consortium, Monash University, Clayton, Victoria 3800, Australia.
  • Daly RJ; Prostate Research Group, Cancer Program-Biomedicine Discovery Institute, Department of Anatomy and Developmental Biology, Monash Partners Comprehensive Cancer Consortium, Monash University, Clayton, Victoria 3800, Australia.
  • Horvath LG; Epigenetics Research Laboratory, Genomics and Epigenetics Division, Garvan Institute of Medical Research, Darlinghurst, Sydney, New South Wales 2010, Australia.
  • Stricker P; Epigenetics Research Laboratory, Genomics and Epigenetics Division, Garvan Institute of Medical Research, Darlinghurst, Sydney, New South Wales 2010, Australia.
  • Frydenberg M; Tissupath Pathology, Mount Waverley, Victoria 3149, Australia.
  • Taylor RA; Tissupath Pathology, Mount Waverley, Victoria 3149, Australia.
  • Stirzaker C; Prostate Research Group, Cancer Program-Biomedicine Discovery Institute, Department of Anatomy and Developmental Biology, Monash Partners Comprehensive Cancer Consortium, Monash University, Clayton, Victoria 3800, Australia.
  • Risbridger GP; Tissupath Pathology, Mount Waverley, Victoria 3149, Australia.
  • Clark SJ; Cancer Research Division, Garvan Institute of Medical Research/The Kinghorn Cancer Centre, Darlinghurst, New South Wales 2010, Australia.
Genome Res ; 28(5): 625-638, 2018 05.
Article em En | MEDLINE | ID: mdl-29650553
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Metilação de DNA / Microambiente Tumoral / Epigenômica Limite: Humans / Male Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Metilação de DNA / Microambiente Tumoral / Epigenômica Limite: Humans / Male Idioma: En Ano de publicação: 2018 Tipo de documento: Article